Trinity Biotech ADR buy StockNews.com
Start price
02.12.23
/
50%
€0.45
Target price
02.12.24
-
Performance (%)
-4.93%
Price
22.02.24
€0.41
Summary
This prediction is currently active. With a performance of -4.93%, the BUY prediction for Trinity Biotech ADR by StockNews_com is down slightly. This prediction currently runs until 02.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat